Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Celladon Corporation - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 27 | Code: MRS - 18612


Global Markets Directs, Celladon Corporation Product Pipeline Review 2014, provides an overview of the Celladon Corporations pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Celladon Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Celladon Corporation including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Celladon Corporations human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Celladon Corporations pipeline products

Reasons to buy

Evaluate Celladon Corporations strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Celladon Corporation in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Celladon Corporations R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Celladon Corporation and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Celladon Corporation
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Celladon Corporation and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
Celladon Corporation Snapshot 4
Celladon Corporation Overview 4
Key Information 4
Key Facts 4
Celladon Corporation- Research and Development Overview 5
Key Therapeutic Areas 5
Celladon Corporation- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Celladon Corporation- Pipeline Products Glance 9
Celladon Corporation- Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Celladon Corporation- Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Celladon Corporation- Drug Profiles 11
Mydicar 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Gene therapy to Activate mSCF for Ischemic Cardiomyopathy 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Small Molecule Modulators of SERCA2b for Metabolic and Neurodegenerative Disorders 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Celladon Corporation- Pipeline Analysis 16
Celladon Corporation- Pipeline Products by Target 16
Celladon Corporation- Pipeline Products by Route of Administration 17
Celladon Corporation- Pipeline Products by Molecule Type 18
Celladon Corporation- Pipeline Products by Mechanism of Action 19
Celladon Corporation- Recent Pipeline Updates 20
Celladon Corporation- Dormant Projects 24
Celladon Corporation- Locations And Subsidiaries 25
Head Office 25

Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 27
Disclaimer 27

List of Tables

Celladon Corporation, Key Information 4
Celladon Corporation, Key Facts 4
Celladon Corporation- Pipeline by Indication, 2014 6
Celladon Corporation- Pipeline by Stage of Development, 2014 7
Celladon Corporation- Monotherapy Products in Pipeline, 2014 8
Celladon Corporation- Phase II, 2014 9
Celladon Corporation- Preclinical, 2014 10
Celladon Corporation- Pipeline by Target, 2014 16
Celladon Corporation- Pipeline by Route of Administration, 2014 17
Celladon Corporation- Pipeline by Molecule Type, 2014 18
Celladon Corporation- Pipeline Products by Mechanism of Action, 2014 19
Celladon Corporation- Recent Pipeline Updates, 2014 20
Celladon Corporation- Dormant Developmental Projects,2014 24

List of Figures
 

Celladon Corporation - Pipeline by Top 10 Indication, 2014 6
Celladon Corporation - Pipeline by Stage of Development, 2014 7
Celladon Corporation - Monotherapy Products in Pipeline, 2014 8
Celladon Corporation - Pipeline by Top 10 Target, 2014 16
Celladon Corporation - Pipeline by Top 10 Route of Administration, 2014 17
Celladon Corporation - Pipeline by Top 10 Molecule Type, 2014 18
Celladon Corporation - Pipeline Products by Top 10 Mechanism of Action, 2014 19

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing